Literature DB >> 34729729

Protamine-The Journey from DNA to Heparin Neutralization to Gene therapy.

Jecko Thachil1.   

Abstract

Protamine is now well recognized as a key heparin neutralizing agent. However, protamine was discovered over a century ago, during experiments performed to uncover the secrets behind heritability. Although protamine was discovered as a highly charged protein, it did not receive the attention it deserved until the dawn of insulin era, when it was used to create the neutral protamine Hagedorn formulation. Based on the same principles, protamine was identified to neutralize heparin and has since been used successfully for many years in cardiothoracic surgery. More recently, its clinical applications have extended to gene therapy. In this historical sketch, the journey from the discovery of protamine, onwards to heparin neutralization, and up to its utilization in genetic modulatory treatments is detailed. Thieme. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34729729     DOI: 10.1055/s-0041-1736574

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  2 in total

1.  Differential Neutralization of Unfractionated Heparin and Enoxaparin by Andexanet Alfa.

Authors:  Joseph Lewis; Omer Iqbal; Walter Jeske; Debra Hoppensteadt; Fakiha Siddiqui; Jawed Fareed
Journal:  Clin Appl Thromb Hemost       Date:  2022 Jan-Dec       Impact factor: 3.512

Review 2.  mRNA vaccines in the prevention and treatment of diseases.

Authors:  Yangzhuo Gu; Jiangyao Duan; Na Yang; Yuxin Yang; Xing Zhao
Journal:  MedComm (2020)       Date:  2022-08-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.